Merck Financial Statements From 2010 to 2026

MRK Stock  USD 121.86  0.20  0.16%   
Analyzing historical trends in various income statement and balance sheet accounts from Merck's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Merck's valuation are summarized below:
Gross Profit
50.1 B
Profit Margin
0.2808
Market Capitalization
303.9 B
Enterprise Value Revenue
4.9915
Revenue
65 B
There are currently one hundred twenty fundamental ratios for Merck that can be evaluated and compared over time across peers in the industry. We recommend to check Merck's last-minute fundamental drivers against the all of the trends between 2010 and 2026. Market Cap is expected to rise to about 178.5 B this year. Enterprise Value is expected to rise to about 194.7 B this year

Merck Total Revenue

32.52 Billion

Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 B, Interest Expense of 1.5 B or Total Revenue of 32.5 B, as well as many indicators such as Price To Sales Ratio of 4.53, Dividend Yield of 0.0238 or PTB Ratio of 6.86. Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
  
Build AI portfolio with Merck Stock
Check out the analysis of Merck Correlation against competitors.

Merck Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets141.4 B134.7 B98.7 B
Slightly volatile
Short and Long Term Debt Total46.2 B44 B28.1 B
Slightly volatile
Other Current Liabilities21.1 B20.1 B13.5 B
Slightly volatile
Total Current Liabilities34.3 B32.7 B21.7 B
Slightly volatile
Total Stockholder Equity26.9 B51.9 B38.4 B
Very volatile
Property Plant And Equipment Net28.7 B27.3 B17 B
Slightly volatile
Retained Earnings76.2 B72.5 B47.9 B
Slightly volatile
Cash19.1 B18.2 B10.3 B
Slightly volatile
Non Current Assets Total94.6 B90.1 B67.4 B
Slightly volatile
Non Currrent Assets Other19.4 B18.5 B9.3 B
Slightly volatile
Cash And Short Term Investments19.1 B18.2 B12.2 B
Pretty Stable
Net Receivables12.4 B11.8 BB
Slightly volatile
Common Stock Shares Outstanding2.8 B2.5 B2.7 B
Slightly volatile
Liabilities And Stockholders Equity141.4 B134.7 B98.7 B
Slightly volatile
Inventory3.8 BB5.4 B
Slightly volatile
Total Current Assets46.8 B44.6 B31.4 B
Slightly volatile
Short Term Debt2.3 B3.4 BB
Pretty Stable
Intangible Assets14.5 B18.8 B18.5 B
Pretty Stable
Accounts Payable2.8 B4.7 B3.2 B
Slightly volatile
Property Plant And Equipment Gross51.8 B49.4 B24.2 B
Slightly volatile
Common Stock Total Equity1.2 B2.1 B1.7 B
Slightly volatile
Capital Stock1.2 B2.1 B1.7 B
Slightly volatile
Common Stock1.2 B2.1 B1.7 B
Slightly volatile
Other Liabilities10.2 B10.5 B10.7 B
Pretty Stable
Other Assets93.3 B88.9 B20.3 B
Slightly volatile
Long Term Debt41.6 B39.6 B24.8 B
Slightly volatile
Good Will12.7 B24.9 B16.9 B
Slightly volatile
Property Plant Equipment17.1 B28.9 B17.2 B
Slightly volatile
Current Deferred Revenue6.6 B5.3 B2.6 B
Slightly volatile
Long Term Debt Total25.5 B39.6 B24.4 B
Slightly volatile
Capital Surpluse45.3 B51.4 B42 B
Slightly volatile
Long Term Investments395.9 M416.7 M5.1 B
Slightly volatile
Short and Long Term Debt3.1 BB2.4 B
Slightly volatile
Non Current Liabilities Other7.6 B5.8 B8.8 B
Very volatile
Cash And Equivalents9.7 B15.2 B8.4 B
Slightly volatile
Net Invested Capital72 B95.9 B64.9 B
Slightly volatile
Net Working Capital6.9 B11.9 B6.6 B
Slightly volatile

Merck Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.9 B4.3 B4.6 B
Slightly volatile
Total Revenue32.5 B65 B44.5 B
Slightly volatile
Gross Profit55.6 B53 B32.8 B
Slightly volatile
Other Operating Expenses24.9 B38.2 B34.8 B
Slightly volatile
Operating Income28.1 B26.8 B10.9 B
Slightly volatile
EBIT22.1 B21.1 B10.9 B
Slightly volatile
EBITDA26.6 B25.4 B15.6 B
Slightly volatile
Cost Of Revenue10.3 B12 B13.8 B
Very volatile
Total Operating Expenses14.6 B26.2 B21.1 B
Slightly volatile
Income Before Tax22.1 B21.1 B10.2 B
Slightly volatile
Net Income19.2 B18.3 B8.6 B
Slightly volatile
Income Tax ExpenseB2.8 BB
Pretty Stable
Research Development8.1 B15.6 B11.2 B
Slightly volatile
Selling General AdministrativeB10.6 BB
Pretty Stable
Net Income Applicable To Common Shares19.2 B18.3 B8.9 B
Slightly volatile
Net Income From Continuing Ops20.7 B19.7 B9.7 B
Slightly volatile
Non Recurring288.1 M303.3 M734.3 M
Slightly volatile
Selling And Marketing Expenses2.1 B2.2 B6.6 B
Slightly volatile
Tax Provision2.4 B2.8 B1.8 B
Slightly volatile
Interest Income707.2 M663 M746.7 M
Pretty Stable
Reconciled Depreciation3.2 BB4.2 B
Slightly volatile
Discontinued Operations563.2 M633.6 M691.6 M
Slightly volatile

Merck Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow21.9 B20.8 B10.5 B
Slightly volatile
Begin Period Cash Flow14 B13.3 B9.7 B
Pretty Stable
Depreciation3.2 B5.2 B4.7 B
Slightly volatile
Dividends Paid9.5 BB5.9 B
Slightly volatile
Total Cash From Operating Activities25.9 B24.7 B13.3 B
Slightly volatile
Net Income19.2 B18.3 B8.6 B
Slightly volatile
End Period Cash Flow16.1 B15.3 B10 B
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.534.05983.889
Slightly volatile
Dividend Yield0.02380.03120.0321
Slightly volatile
PTB Ratio6.865.08474.9723
Slightly volatile
Days Sales Outstanding69.9167.2363.7879
Pretty Stable
Book Value Per Share21.7420.701415.0453
Slightly volatile
Free Cash Flow Yield0.04220.06470.0532
Pretty Stable
Operating Cash Flow Per Share8.017.634.7693
Slightly volatile
Stock Based Compensation To Revenue0.00730.01070.0086
Slightly volatile
Capex To Depreciation1.350.860.7778
Slightly volatile
PB Ratio6.865.08474.9723
Slightly volatile
EV To Sales3.433.77964.1179
Slightly volatile
Free Cash Flow Per Share6.756.433.7418
Slightly volatile
ROIC0.150.220.1016
Slightly volatile
Inventory Turnover2.192.242.5397
Pretty Stable
Net Income Per Share7.647.283.2746
Slightly volatile
Days Of Inventory On Hand175169147
Slightly volatile
Payables Turnover3.893.354.7405
Slightly volatile
Sales General And Administrative To Revenue0.080.110.0738
Slightly volatile
Research And Ddevelopement To Revenue0.140.23990.2315
Slightly volatile
Capex To Revenue0.07570.06040.0609
Slightly volatile
Cash Per Share7.637.2644.5528
Slightly volatile
POCF Ratio17.9513.4915.8113
Pretty Stable
Interest Coverage12.3918.312.2716
Very volatile
Payout Ratio0.430.45051.959
Pretty Stable
Capex To Operating Cash Flow0.290.180.2383
Pretty Stable
PFCF Ratio25.6516.0121.5284
Pretty Stable
Days Payables Outstanding14211396.6049
Pretty Stable
Income Quality2.131.133.7037
Pretty Stable
ROE0.320.35170.214
Slightly volatile
EV To Operating Cash Flow18.8614.8317.189
Pretty Stable
PE Ratio13.7414.458868.6201
Pretty Stable
Return On Tangible Assets0.180.250.1328
Slightly volatile
EV To Free Cash Flow26.9417.623.4169
Pretty Stable
Earnings Yield0.05710.06920.0457
Very volatile
Intangibles To Total Assets0.220.290.3417
Very volatile
Current Ratio1.621.571.5445
Slightly volatile
Receivables Turnover4.785.625.7673
Very volatile
Graham Number61.1458.231331.3254
Slightly volatile
Shareholders Equity Per Share21.7420.701414.8706
Slightly volatile
Debt To Equity0.780.740.7056
Slightly volatile
Capex Per Share0.651.20.9916
Slightly volatile
Revenue Per Share27.2225.927517.5571
Slightly volatile
Interest Debt Per Share14.7614.0510.5032
Slightly volatile
Debt To Assets0.310.290.2704
Slightly volatile
Enterprise Value Over EBITDA10.819.68914.3997
Slightly volatile
Short Term Coverage Ratios6.089.325.8502
Slightly volatile
Price Earnings Ratio13.7414.458868.6201
Pretty Stable
Operating Cycle245236211
Pretty Stable
Price Book Value Ratio6.865.08474.9723
Slightly volatile
Days Of Payables Outstanding14211396.6049
Pretty Stable
Dividend Payout Ratio0.430.45051.959
Pretty Stable
Price To Operating Cash Flows Ratio17.9513.4915.8113
Pretty Stable
Price To Free Cash Flows Ratio25.6516.0121.5284
Pretty Stable
Pretax Profit Margin0.30.32410.2111
Pretty Stable
Ebt Per Ebit1.220.78671.0043
Pretty Stable
Operating Profit Margin0.280.41190.2145
Slightly volatile
Effective Tax Rate0.130.13310.2586
Very volatile
Company Equity Multiplier1.92.282.4591
Slightly volatile
Long Term Debt To Capitalization0.40.380.3587
Slightly volatile
Total Debt To Capitalization0.230.410.3841
Slightly volatile
Return On Capital Employed0.240.260.1397
Slightly volatile
Debt Equity Ratio0.780.740.7056
Slightly volatile
Ebit Per Revenue0.280.41190.2145
Slightly volatile
Quick Ratio0.941.031.2187
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.612.21.4906
Pretty Stable
Net Income Per E B T0.580.86650.7835
Very volatile
Cash Ratio0.340.420.4787
Slightly volatile
Cash Conversion Cycle85.0996.51127
Slightly volatile
Operating Cash Flow Sales Ratio0.220.30.2587
Slightly volatile
Days Of Inventory Outstanding175169147
Slightly volatile
Days Of Sales Outstanding69.9167.2363.7879
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.590.760.7511
Slightly volatile
Cash Flow Coverage Ratios1.280.650.6687
Pretty Stable
Price To Book Ratio6.865.08474.9723
Slightly volatile
Fixed Asset Turnover2.072.432.762
Slightly volatile
Capital Expenditure Coverage Ratio3.535.734.8648
Slightly volatile
Price Cash Flow Ratio17.9513.4915.8113
Pretty Stable
Enterprise Value Multiple10.819.68914.3997
Slightly volatile
Debt Ratio0.310.290.2704
Slightly volatile
Cash Flow To Debt Ratio1.280.650.6687
Pretty Stable
Price Sales Ratio4.534.05983.889
Slightly volatile
Return On Assets0.130.170.087
Slightly volatile
Asset Turnover0.680.630.5053
Slightly volatile
Net Profit Margin0.220.28080.1718
Slightly volatile
Gross Profit Margin0.770.8150.6889
Slightly volatile
Price Fair Value6.865.08474.9723
Slightly volatile
Return On Equity0.320.35170.214
Slightly volatile

Merck Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap178.5 B170 B155.3 B
Slightly volatile
Enterprise Value194.7 B185.4 B169.4 B
Slightly volatile

Merck Fundamental Market Drivers

Forward Price Earnings23.6407
Cash And Short Term Investments18.2 B

Merck Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
6th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Merck Financial Statements

Merck investors utilize fundamental indicators, such as revenue or net income, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.3 B6.6 B
Total Revenue65 B32.5 B
Cost Of Revenue12 B10.3 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.11  0.08 
Research And Ddevelopement To Revenue 0.24  0.14 
Capex To Revenue 0.06  0.08 
Revenue Per Share 25.93  27.22 
Ebit Per Revenue 0.41  0.28 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. Expected growth trajectory for Merck significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Merck assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.19)
Dividend Share
3.24
Earnings Share
7.28
Revenue Per Share
25.932
Quarterly Revenue Growth
0.05
Understanding Merck Company requires distinguishing between market price and book value, where the latter reflects Merck's accounting equity. The concept of intrinsic value - what Merck's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Merck's price substantially above or below its fundamental value.
Understanding that Merck's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merck represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Merck's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.